Bronte Capital Management Pty Ltd. Cuts Stock Position in Herbalife Ltd. (NYSE:HLF)

Bronte Capital Management Pty Ltd. lessened its stake in shares of Herbalife Ltd. (NYSE:HLFFree Report) by 3.9% in the 2nd quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 2,696,608 shares of the company’s stock after selling 108,645 shares during the period. Herbalife accounts for approximately 2.3% of Bronte Capital Management Pty Ltd.’s investment portfolio, making the stock its 15th biggest position. Bronte Capital Management Pty Ltd.’s holdings in Herbalife were worth $28,018,000 at the end of the most recent reporting period.

Several other institutional investors also recently bought and sold shares of HLF. Windacre Partnership LLC boosted its position in Herbalife by 3.4% during the first quarter. Windacre Partnership LLC now owns 9,203,500 shares of the company’s stock worth $92,495,000 after acquiring an additional 300,000 shares during the last quarter. Baupost Group LLC MA boosted its holdings in shares of Herbalife by 33.6% during the 1st quarter. Baupost Group LLC MA now owns 2,244,923 shares of the company’s stock worth $22,561,000 after purchasing an additional 565,124 shares during the last quarter. Charles Schwab Investment Management Inc. grew its position in shares of Herbalife by 8.4% in the fourth quarter. Charles Schwab Investment Management Inc. now owns 1,888,191 shares of the company’s stock valued at $28,814,000 after purchasing an additional 145,684 shares in the last quarter. Hotchkis & Wiley Capital Management LLC increased its holdings in shares of Herbalife by 7.7% in the fourth quarter. Hotchkis & Wiley Capital Management LLC now owns 1,624,370 shares of the company’s stock valued at $24,788,000 after purchasing an additional 116,030 shares during the last quarter. Finally, LSV Asset Management lifted its position in Herbalife by 47.0% during the second quarter. LSV Asset Management now owns 1,556,902 shares of the company’s stock worth $16,176,000 after buying an additional 497,919 shares in the last quarter.

Insiders Place Their Bets

In other news, Director Juan Miguel Mendoza acquired 10,000 shares of Herbalife stock in a transaction on Monday, September 9th. The stock was bought at an average price of $7.11 per share, for a total transaction of $71,100.00. Following the completion of the purchase, the director now owns 120,000 shares in the company, valued at $853,200. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Corporate insiders own 0.94% of the company’s stock.

Herbalife Stock Performance

Shares of NYSE HLF opened at $6.82 on Tuesday. The stock’s 50-day simple moving average is $9.79 and its 200-day simple moving average is $9.76. The firm has a market capitalization of $686.91 million, a PE ratio of 4.98 and a beta of 1.21. Herbalife Ltd. has a fifty-two week low of $6.68 and a fifty-two week high of $15.71.

Herbalife (NYSE:HLFGet Free Report) last issued its quarterly earnings data on Wednesday, July 31st. The company reported $0.54 earnings per share for the quarter, topping the consensus estimate of $0.43 by $0.11. Herbalife had a net margin of 1.63% and a negative return on equity of 18.69%. The business had revenue of $1.28 billion during the quarter, compared to the consensus estimate of $1.33 billion. During the same quarter in the previous year, the firm earned $0.74 EPS. The company’s revenue was down 2.5% compared to the same quarter last year. On average, sell-side analysts forecast that Herbalife Ltd. will post 0.9 earnings per share for the current fiscal year.

Analyst Upgrades and Downgrades

A number of equities analysts recently weighed in on HLF shares. DA Davidson increased their price objective on shares of Herbalife from $9.50 to $13.00 and gave the stock a “neutral” rating in a research report on Thursday, August 1st. StockNews.com cut Herbalife from a “buy” rating to a “hold” rating in a research note on Thursday, September 5th. Mizuho increased their target price on Herbalife from $10.00 to $11.00 and gave the stock a “neutral” rating in a research note on Friday, June 7th. Finally, B. Riley boosted their price target on shares of Herbalife from $16.00 to $17.00 and gave the stock a “buy” rating in a research note on Thursday, August 1st. One equities research analyst has rated the stock with a sell rating, five have issued a hold rating and one has assigned a buy rating to the company. According to data from MarketBeat.com, the company currently has an average rating of “Hold” and a consensus target price of $12.33.

View Our Latest Research Report on HLF

Herbalife Profile

(Free Report)

Herbalife Ltd. provides health and wellness products in North America, Mexico, South and Central America, Europe, the Middle East, Africa, China, and the Asia Pacific. It offers products in the areas of weight management; targeted nutrition; energy, sports, and fitness; outer nutrition; and literature and promotional items.

Featured Stories

Want to see what other hedge funds are holding HLF? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Herbalife Ltd. (NYSE:HLFFree Report).

Institutional Ownership by Quarter for Herbalife (NYSE:HLF)

Receive News & Ratings for Herbalife Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Herbalife and related companies with MarketBeat.com's FREE daily email newsletter.